Indications for use
Prevention and symptomatic treatment of obstructive airway diseases with reversible airway obstruction: chronic obstructive pulmonary disease (COPD), bronchial asthma, chronic bronchitis complicated or uncomplicated by emphysema.
Therapeutic class:
Combined bronchodilator
INN
Ipratropium bromide + Fenoterol
MDI — Metered Dose Inhaler
We use cookies in accordance with the cookie policy to ensure you get the best experience on our website.